Advances in the treatment of anxiety: targeting glutamate.
about
How antipsychotics work-from receptors to reality.The endocannabinoid system in anxiety, fear memory and habituation.Pharmacological treatments that facilitate extinction of fear: relevance to psychotherapy.Glutamate-modulating drugs as novel pharmacotherapeutic agents in the treatment of obsessive-compulsive disorder.An Experimental Study to Evaluate the Effect of Memantine in Animal Models of Anxiety in Swiss Albino Mice.Differential effects of diazepam and MPEP on habituation and neuro-behavioural processes in inbred miceAlterations in NMDA receptor subunit densities and ligand binding to glycine recognition sites are associated with chronic anxiety in Alzheimer's diseaseAdolescent Mice Are Resilient to Alcohol Withdrawal-Induced Anxiety and Changes in Indices of Glutamate Function within the Nucleus Accumbens.Lamotrigine augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a double-blind, placebo-controlled study.Impaired 2-AG Signaling in Hippocampal Glutamatergic Neurons: Aggravation of Anxiety-Like Behavior and Unaltered Seizure Susceptibility.Glutamate dysregulation and glutamatergic therapeutics for PTSD: Evidence from human studies.Reward memory relieves anxiety-related behavior through synaptic strengthening and protein kinase C in dentate gyrus.Finding what you are not looking for: strategies for developing novel treatments in psychiatry.Protein kinase C is essential for kainate-induced anxiety-related behavior and glutamatergic synapse upregulation in prelimbic cortex.
P2860
Q30457477-351844B4-5492-4C98-B173-45157C12ACFEQ30471032-6F6D6DB1-E2C9-45A2-8692-208627CCF621Q30480038-897FAAE3-2F14-46F7-B02D-9995DB07607CQ31032734-108B11EB-5D04-4E9B-9CEE-E516A892D98EQ36077324-5D776684-63C8-4049-8FB3-B8B88FFB8AF9Q36298966-287D6B1A-9257-4335-AFD3-E8171F367436Q37155987-5D364581-97C1-4F13-9C76-E4CB54A6443EQ37421133-DD098EF0-DF49-42F5-9E36-7E821AE17717Q38475793-15A58BCE-33FE-4157-9E26-1B4429B5F5F7Q38697360-BB77D336-B4EE-4D06-940B-1B2429AEE1C9Q38787388-10EED97C-48C6-4329-A37C-4610F37F5E6BQ39182365-83EA4DAF-D22C-4E86-AC51-BB16FFF84725Q41358274-8297642D-9779-4329-98AD-525ACC3FBFACQ47820916-29DB232F-8B53-4306-9529-85CCD23F88C8
P2860
Advances in the treatment of anxiety: targeting glutamate.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Advances in the treatment of anxiety: targeting glutamate.
@ast
Advances in the treatment of anxiety: targeting glutamate.
@en
type
label
Advances in the treatment of anxiety: targeting glutamate.
@ast
Advances in the treatment of anxiety: targeting glutamate.
@en
prefLabel
Advances in the treatment of anxiety: targeting glutamate.
@ast
Advances in the treatment of anxiety: targeting glutamate.
@en
P2860
P1433
P1476
Advances in the treatment of anxiety: targeting glutamate.
@en
P2093
Asher B Simon
Jack M Gorman
P2860
P356
10.1016/J.NURX.2005.12.005
P577
2006-01-01T00:00:00Z